Thus, the potent molecular interaction of docetaxel with ABCB1 and CYP1B1 (Table 4 and Figure 7 and Figure 8) may insinuate potential resistance of the cancer cells to docetaxel via increased expression of ABCB1 and CYP1B1. The gene discussed is CYP1B1; the disease is cancer.